We report the clinical case of a nine-year-old girl who presented with progressive motor neuropathy, revealed via the detection of a higher delay in F-wave recording using digitalized nerve conduction/electromyography. Since the lupus anticoagulant (LAC) positivity, detected using diluted Russell viper venom time (dRVVT), switched to persistent serological anticardiolipin immunoglobulin G (IgG) positivity, a possible non-thrombotic antiphospholipid antibody (aPL)-related clinical manifestation was suspected, and intravenous immunoglobulin treatment (IVIG) was started. The IVIG treatment was well tolerated and the complete resolution of motor impairment was obtained after the third IVIG infusion. Our findings suggest that it could be useful to check for antiphospholipid antibodies in children with a rapid onset of progressive neurological signs in order to provide the beneficial use of IVIG in the treatment of pediatric aPL neurological conditions.
Brogna, C., Luigetti, M., Norcia, G., Scalise, S., Ferrantini, G., Berti, B., Romeo, D. M. M., Manna, R., Mercuri, E. M., Pane, M., (Abstract) Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies., <<BRAIN SCIENCES>>, 2020; (10): N/A-N/A. [doi:10.3390/brainsci10030156] [http://hdl.handle.net/10807/151774]
Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies.
Brogna, Claudia;Luigetti, Marco;Scalise, Sara;Ferrantini, Gloria;Romeo, Domenico Marco Maurizio;Manna, Raffaele;Mercuri, Eugenio Maria;Pane, Marika
2020
Abstract
We report the clinical case of a nine-year-old girl who presented with progressive motor neuropathy, revealed via the detection of a higher delay in F-wave recording using digitalized nerve conduction/electromyography. Since the lupus anticoagulant (LAC) positivity, detected using diluted Russell viper venom time (dRVVT), switched to persistent serological anticardiolipin immunoglobulin G (IgG) positivity, a possible non-thrombotic antiphospholipid antibody (aPL)-related clinical manifestation was suspected, and intravenous immunoglobulin treatment (IVIG) was started. The IVIG treatment was well tolerated and the complete resolution of motor impairment was obtained after the third IVIG infusion. Our findings suggest that it could be useful to check for antiphospholipid antibodies in children with a rapid onset of progressive neurological signs in order to provide the beneficial use of IVIG in the treatment of pediatric aPL neurological conditions.File | Dimensione | Formato | |
---|---|---|---|
brainsci-10-00156-v2.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
216.01 kB
Formato
Adobe PDF
|
216.01 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.